The most significant advance is the ability to diagnose infants from genetic testing. This allows treatment to begin in early adolescents, thereby avoiding many of the social and emotional problems experienced by KS patients.
Other advances are in terms of hormone replacement therapy. These are slow to be authorized in the US and even slower to be accepted by insurance. However, some of these advances are gels, creams, patches, implants, and quarterly (as opposed to weekly) injections